prodermic | clinical documentation

555 PROCEDURE GUIDE

Depigment Protocol — Step-by-Step Clinical Application Guide for Practitioners

5-Agent Combo Peel Self-Neutralizing · 3–5 Hr Contact Fitzpatrick III–V

Product Overview

prodermic 555 De-Pigmento

prodermic® 555

Depigment Protocol · 5-Agent Combo Peel

Type5-Agent Combo Peel
Total Active5-agent combination
Size30ml jar
Yield~24 sessions per jar
FitzpatrickIII–V
Peel DepthSuperficial

Active Composition

Arginine
Mandelic
Kojic
Lactic
Glycolic

Mechanism of Action

AgentMechanism
ArginineAmino acid and nitric oxide precursor — enhances microcirculation and active ingredient delivery to pigmented areas. Accelerates cellular repair in pigment-damaged skin.
Mandelic AcidLipophilic AHA with large molecular weight — slower, more even penetration avoiding patchy results common with glycolic-only systems. Broad-spectrum antibacterial. Works well across oily and dry zones.
Kojic AcidChelates copper ions required for enzymatic melanogenesis, providing sustained pigment-blocking action at the tyrosinase level.
Lactic AcidHydrating exfoliation with ceramide synthesis support. Strengthens skin barrier while promoting controlled desquamation of pigmented keratinocytes.
Glycolic AcidSurface-level exfoliation — disrupts corneocyte cohesion to accelerate turnover of hyperpigmented superficial layers.

Clinical Indications

Deep Pigmentation
Deep Pigmentation
Fitzpatrick III-V
Fitzpatrick III–V
Stubborn Melasma
Stubborn Melasma

Patient Selection & Pre-Procedure

Ideal Patient Profile

Contraindications

DO NOT TREAT IF

Pre-Procedure Patient Preparation

  1. Skin Assessment: Evaluate skin type, pigmentation depth and distribution, melasma pattern, and prior peel/depigmentation history to determine suitability.
  2. Sun Exposure: Advise patient to avoid direct sun exposure for at least 1 week prior.
  3. Discontinue: Stop topical retinoids 72 hours before. Stop AHAs/BHAs 48 hours before.
  4. Informed Consent: Discuss expected outcomes, downtime (3–5 days of peeling/flaking), self-neutralizing nature (patient washes off at home), and possible side effects.
  5. Photography: Take standardized baseline photographs under consistent lighting. Use a Wood’s lamp if available to assess pigment depth.

Step-by-Step Procedure

KEY: SELF-NEUTRALIZING FORMULA

prodermic 555 is a self-neutralizing peel. It is applied in-clinic and the patient leaves with the peel on. The peel self-neutralizes over 3–5 hours. The patient washes it off at home after the contact period. No in-clinic neutralization is required.

01
Cleanse & Degrease
Cleanse the treatment area with a gentle, non-residue cleanser. Remove all makeup, sunscreen, and surface impurities. Then degrease the skin using a pre-peel degreasing solution (e.g., glycolic prep, acetone, or alcohol prep) applied with gauze or cotton pads. Wipe across the entire treatment area to ensure uniform acid penetration.
Degreasing contact: 1–2 minutes. Wipe clean. Allow skin to dry for 30 seconds before proceeding.
02
Patch Test (First Session Only)
For the patient's first session, perform a mandatory patch test. Apply a small amount of prodermic 555 to the post-auricular area (behind the ear). Wait 10 minutes and observe for signs of excessive irritation, burning, or allergic reaction.
If the patient shows no adverse reaction after 10 minutes, proceed with full application. If irritation occurs, do NOT proceed — remove product immediately and consider a milder protocol.
03
Apply prodermic 555
Using a fan brush, apply a thin, even layer of prodermic 555 across the entire treatment area. This is a 5-agent formula with a unique arginine component that enhances blood flow and delivery of the depigmenting actives. Work systematically:
  1. Forehead: Apply in horizontal strokes from center outward
  2. Cheeks: Apply from the nose outward toward the ears — focus on pigmented patches
  3. Nose: Apply evenly across the bridge and sides
  4. Chin: Apply in upward strokes
  5. Upper lip: Light, thin application (sensitive area, common melasma zone)
Use approximately 1–1.25ml of product per full-face application. Avoid the periorbital area (around eyes), lips, and nostrils. Pay extra attention to hyperpigmented areas but maintain even coverage for uniform results.
04
Observe Initial Response (5–10 Minutes)
After application, observe the patient in-clinic for 5–10 minutes to ensure no adverse immediate reactions. Mild warmth and slight tingling are normal and expected. The mandelic acid provides a gentler onset than glycolic-dominant peels.
  • Mild warmth + tingling: Normal — this is the expected initial response from the multi-acid formula
  • Moderate stinging: Monitor for 2–3 more minutes; usually subsides as the peel begins self-neutralizing
  • Severe burning or swelling: Remove product immediately with cold water
Once you confirm tolerance, the patient is ready for discharge with at-home instructions.
05
Discharge with At-Home Instructions
Once the initial observation is complete and the patient shows no adverse reaction:
  1. Leave the peel on: The patient leaves with the peel on their face
  2. Contact time: Instruct the patient to leave it on for 3–5 hours
  3. Wash off at home: After 3–5 hours, rinse thoroughly with lukewarm water until all residue is removed
  4. Apply a soothing recovery moisturizer immediately after washing
  5. No other actives or makeup for the rest of the day
Provide the patient with written or WhatsApp post-care instructions before they leave. Schedule next session in 14 days.
06
Post-Peel Soothing (At Home)
After washing off the peel at home:
  1. Pat skin dry gently — do not rub
  2. Apply a thick, bland recovery moisturizer or balm generously
  3. Do not apply any actives, serums, or makeup until the next morning
  4. Sleep on a clean pillowcase
Mild redness post-wash is normal and will subside within a few hours. The skin may feel tight — this is expected as the depigmentation process continues.

Early Removal & Adverse Reactions

INSTRUCT PATIENT TO WASH OFF IMMEDIATELY IF

Emergency Removal Steps (At Home)

  1. Rinse the treatment area thoroughly with cold water until all product is removed
  2. Continue rinsing until all tingling/burning completely stops
  3. Apply a thick, bland moisturizer (no actives)
  4. Apply a cold compress for comfort if needed
  5. Contact the clinic immediately to report the reaction
  6. Document the reaction — reduce contact time or consider a milder protocol for the next session

PATIENT COMMUNICATION

Post-Procedure Care Instructions

Provide these instructions to the patient (verbal + printed/WhatsApp):

Day 0 (Day of Procedure)

Days 1–2 (Tightness Phase)

Days 3–5 (Peeling Phase)

Days 5–7 (Recovery Phase)

Days 7–14 (Between Sessions)

Expected Peeling Timeline

Day 0
Application
Applied in-clinic, wash off at home after 3–5 hrs
Day 1–2
Tightness
Skin feels tight, may darken slightly
Day 3–5
Peeling Phase
Visible flaking & shedding
Day 5–7
Fresh Skin
Fresh, brighter skin visible
Day 14
Next Session
Repeat protocol

Treatment Program

ParameterRecommendation
Total Sessions4–6 sessions (assess at session 3)
Session Interval14 days between sessions
Contact Time3–5 hours (self-neutralizing, washed off at home)
Downtime3–5 days peeling/flaking per session
Full Program Duration2–3 months (4–6 sessions at 14-day intervals)
Product per SessionApproximately 1–1.25ml (full face)
Yield per Jar~24 full-face sessions from one 30ml jar
Maintenance1 session every 4–6 weeks after initial program, or as needed

Progressive Protocol Guide

Adjust contact time progressively across sessions based on patient tolerance:

SessionContact TimeNotes
Session 13 hoursConservative first exposure. Assess skin response and tolerance the next day.
Session 23–4 hoursIncrease if Session 1 was well tolerated with no adverse effects.
Session 34 hoursAssess clinical depigmentation results so far. Adjust protocol if needed.
Session 4+4–5 hoursMaximum contact time. Do not exceed 5 hours.

Expected Outcomes

Set realistic expectations: Deep, longstanding pigmentation (melasma, dermal PIH) may require the full 6-session program and ongoing maintenance. Sun protection compliance is critical — any UV exposure between sessions can reverse depigmentation progress.

Full Ingredient List

Arginine, Mandelic Acid, Kojic Acid, Lactic Acid, Glycolic Acid, Liquorice Extract, Tea Tree Extract

Clinical Results

Real patient outcomes with prodermic 555. Tap the image to enlarge.

prodermic 555 depigmentation result
tap to enlarge

prodermic

for medical professionals only
This document is intended for trained dermatologists and aestheticians only. Do not distribute to patients. For ordering and support: wa.me/918208708438